Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer
Tara Akhtarkhavari, Ahmad Reza Bahrami, Maryam Moghaddam Matin
European Journal of Pharmacology (2022) Vol. 932, pp. 175233-175233
Closed Access | Times Cited: 19

Showing 19 citing articles:

Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 63
Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma
Amir Abrishami, Ahmad Reza Bahrami, Amir Sh. Saljooghi, et al.
Nanoscale (2024) Vol. 16, Iss. 12, pp. 6215-6240
Closed Access | Times Cited: 14
Anticancer Potential of Antimicrobial Peptides: Focus on Buforins
Ana Maria Tolos, Cristian Moisă, Mihaela Dochia, et al.
Polymers (2024) Vol. 16, Iss. 6, pp. 728-728
Open Access | Times Cited: 12
Chemoresistance and the tumor microenvironment: the critical role of cell–cell communication
Bartosz Wilczyński, Alicja Dąbrowska, Julita Kulbacka, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
miR-21 promotes cervical cancer by regulating NTF3
Yishan Chen, Caiwu Su, Yong Cai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications
Jessica N. Ziegler, Changhai Tian
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15206-15206
Open Access | Times Cited: 13
Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways
József Király, Erzsébet Szabó, Petra Fodor, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6725-6725
Open Access | Times Cited: 11
Layered Double Hydroxide LDH-Loaded miR-141–3p Targets RAB10 Suppressing Cellular Autophagy to Reverse Paclitaxel Resistance in Breast Cancer
Shuang Tao, Yuxin Ji, Ruonan Li, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5886-5899
Open Access
PTEN-Mediated Resistance in Cancer: From Foundation to Future Therapies
Muhammad Tufail
Toxicology Reports (2025) Vol. 14, pp. 101987-101987
Open Access
Exosomal miRNA-based theranostics in cervical cancer: bridging diagnostics and therapy
Neha R. Raghani, Mehul R. Chorawala, Kunal Parekh, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
CRISPR-empowered electrochemical biosensor for target amplification-free and sensitive detection of miRNA
Chihong Ma, Qin Zhou, Jinjin Shi, et al.
Talanta (2023) Vol. 266, pp. 125125-125125
Closed Access | Times Cited: 9
The impact of microRNAs on the resistance of breast cancer subtypes to chemotherapy
Amir Ebrahimi, Peyman Bakhshaei Shahrebabaki, Hadi Fouladi, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154702-154702
Closed Access | Times Cited: 8
miRStart 2.0: enhancing miRNA regulatory insights through deep learning-based TSS identification
Jiatong Xu, Jingting Wan, Hsi‐Yuan Huang, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D138-D146
Open Access | Times Cited: 3
microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB
Gaozhong Sun, Kewei Ni, Jian Shen, et al.
Critical Reviews in Eukaryotic Gene Expression (2024) Vol. 34, Iss. 4, pp. 13-23
Closed Access | Times Cited: 2
Lnc NBAT1 Inhibits the Proliferation and Migration of Liver Cancer Cells Through the miR-21/PDCD4/AP-1 Signaling Axis
Hongyan Zai, Xinyu Wu, Yi-Fan Zhou, et al.
Applied Biochemistry and Biotechnology (2024)
Closed Access | Times Cited: 1
Application and development of CRISPR-Cas12a methods for the molecular diagnosis of cancer: A review
Sidan Wang, Xiaoyu Shen, Guanxiao Chen, et al.
Analytica Chimica Acta (2024) Vol. 1341, pp. 343603-343603
Closed Access | Times Cited: 1
Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
Mahrou Vahabi, Geng Xu, Amir Avan, et al.
Nucleosides Nucleotides & Nucleic Acids (2024) Vol. 43, Iss. 8, pp. 837-850
Closed Access
Buforins: A Potential Antimicrobial Peptide Explored With Its Anticancer Efficacy‐A Review
Samrat Adhikari, Jitendra Jena, Sanjeeb Kumar Kar, et al.
Peptide Science (2024) Vol. 117, Iss. 1
Closed Access
Transfecção celular de anti-miR-21 aplicada em linhagem de carcinoma renal de células claras metastáticas
Vitoria Ghazarian Nunes
(2023)
Open Access
Page 1

Scroll to top